Financial Statements

Chembio Diagnostics, Inc. (CEMI)

$ 2.4011
-0.01 (-0.37%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2020 2019 2018 2017 2016
Retained Earnings (Previous Year) -72-58-50-44-
Net Income -26-14-8-6-13
Stock Dividends -----30
Dividend Paid -----
Retained Earnings -97-72-58-50-44

PPE Schedule

Year 2020 2019 2018 2017 2016
Gross PPE 13322-
Annual Depreciation 614212
Capital Expenditure -4-4-1-1-0
Net PPE 1513322

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017 2016
Intangible and Goodwill (Previous Year) --3910
New Purchases -----
Intangible and Goodwill -391010

Chembio Diagnostics, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Chembio Diagnostics, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.